Drawing for SELUXDX

USPTO serial 88099614

SELUXDX

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
NITKIN, DINISHA F
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SELUXDX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jessica L. Rothstein

Jessica L. Rothstein Goodwin Procter LLP620 Eighth AvenueNew York, NY 10018UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Reagents for scientific or medical research use; diagnostic reagents for clinical or medical laboratory use; diagnostic preparations for clinical or medical laboratory use; diagnostic preparations for scientific or research use; chemicals for use in industry and science; chemicals for use in industry and science, namely, chemical solutions, reagents, and diagnostic test kits consisting primarily of reagents, test cards, and applicator sticks to control and detect contaminating substances in industrial, agricultural, cosmetic, and pharmaceutical products for scientific or research useACTIVE—
005Reagents for medical use; clinical medical reagents; diagnostic preparations for medical purposes; diagnostic test kits consisting primarily of medical diagnostic reagents, and also including chemicals, nucleic acid probes, antimicrobial agents, and containers, for use in disease testing, microbial testing, and microorganism testing; reagents and media for medical and veterinary diagnosisACTIVE—
009Scientific instruments, namely, portable and benchtop imagers and analyzers that use light scattering, microscopy, and image analysis software to detect, quantify, and bind biological or chemical molecules; scientific apparatus and instruments for controlling and detecting contaminating substances in industrial, agro-foodstuff, cosmetic and pharmaceutical products; diagnostic apparatus and instruments, not for medical use, namely, laboratory equipment and devices used for manual or automated testing in industrial applications that isolate, identify, quantify, reveal, control, and detect contaminating substances, namely, for the analysis of an industrial sample, a cosmetic sample, or an environmental sample to determine contaminants, to determine composition, and to control quality; software used to process and interpret the results of industrial testing that isolates, identifies, quantifies, reveals, controls, and detects contaminating substancesACTIVE—
010Medical diagnostic apparatus for analyzing and measuring bacteria in the body; apparatus and instruments for medical and veterinary diagnosis, namely, equipment and devices in the nature of immuno-analyzers, nucleic acid analyzers, bacteriologic analyzers, and microbiologic analyzers used for testing or for manual or for automated testing of pathogens in medical and clinical applicationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 24, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 24, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 8, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 7, 2022EX5GSOU EXTENSION 5 GRANTED—
Mar 2, 2022EXT5SOU EXTENSION 5 FILED—
Mar 2, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 28, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 28, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 28, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 28, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 28, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 14, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 10, 2021EX4GSOU EXTENSION 4 GRANTED—
Sep 10, 2021EXT4SOU EXTENSION 4 FILED—
Sep 10, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 10, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 8, 2021EX3GSOU EXTENSION 3 GRANTED—
Mar 8, 2021EXT3SOU EXTENSION 3 FILED—
Mar 8, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 10, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 8, 2020EX2GSOU EXTENSION 2 GRANTED—
Sep 8, 2020EXT2SOU EXTENSION 2 FILED—
Sep 8, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 6, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 4, 2020EX1GSOU EXTENSION 1 GRANTED—
Mar 4, 2020EXT1SOU EXTENSION 1 FILED—
Mar 4, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 4, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 4, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 8, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Sep 17, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 23, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 23, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 3, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 19, 2019ALIEASSIGNED TO LIE—
Jun 7, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 4, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 4, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 4, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 4, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 6, 2018GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 6, 2018GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 6, 2018CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Nov 29, 2018DOCKASSIGNED TO EXAMINER—
Sep 9, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 3, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance